Advertisement
News
Subscribe to MDT Magazine News

New Study Results Presented on Dexlansoprazole and Lansoprazole Effects on Plavix® (clopidogrel bisulfate)

April 5, 2011 10:34 am | by Bio-Medicine.Org | Comments

NEW ORLEANS, April 5, 2011 /- Takeda Pharmaceuticals North America, Inc. (Takeda) announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate). The results showed that in...

TOPICS:

NeuroVasx Receives FDA Approval for cPAX Aneurysm Treatment System

April 5, 2011 10:34 am | by Bio-Medicine.Org | Comments

MAPLE GROVE, Minn., April 5, 2011 /- NeuroVasx announced today that the FDA has approved the cPAX Aneurysm Treatment System as a Humanitarian Use Device (HDE) for the treatment of large, giant and wide-neck cerebral aneurysms, which are typically the most difficult to treat.  The HDE...

TOPICS:

Soy Isoflavones Not a Risk for Breast Cancer Survivors

April 5, 2011 10:33 am | by AACR | Comments

Tweet • Cancer recurrence did not increase in survivors who ate soy food. • A trend toward a reduction in mortality and recurrence was observed. • Study is one of the first in the new After Breast Cancer Pooling Project. ORLANDO, Fla. - Soy food consumption did not increase the risk of...

TOPICS:
Advertisement

Covidien reports positive results with belly button surgery

April 5, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Single-incision gall bladder surgery appears just as safe and effective as traditional laparoscopic procedures, according to interim data released by Covidien plc at the Society of American Gastrointestinal and Endoscopic Surgeons meeting in San Antonio.

PMA Final Decisions for January 2011

April 5, 2011 8:38 am | by U.S. Food & Drug Administration | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for January 2011.

Aribex and IDENS Donate 15 Victim I.D. Kits for Japan

April 5, 2011 8:36 am | by Bio-Medicine.Org | Comments

OREM, Utah, April 5, 2011 /- Aribex®, Inc., the worldwide leader in handheld x-ray technologies, has joined with IDENS Co. Ltd., the leading maker of Japan's premier Practice Management System for dental clinics, to contribute up to 15 x-ray kits for forensic victim identification...

TOPICS:

Vancouver Radiologists Leverages MedInformatix RIS as Practice Management Hub, Data Mining Tool to Improve Workflow and Enhance Efficiencies

April 5, 2011 8:34 am | by Bio-Medicine.Org | Comments

VANCOUVER, Wash., April 5, 2011 /- Vancouver Radiologists, P.C., a full-spectrum provider of diagnostic imaging services to residents in and around the greater Vancouver, Wash., and Portland, Ore., areas, has synergized and streamlined overall practice operations through the use of...

TOPICS:

Medicomp, Inc. Announces Company Purchase From United Therapeutics

April 5, 2011 8:34 am | by Bio-Medicine.Org | Comments

MELBOURNE, Fla., April 5, 2011 /- Medicomp Inc., previously a wholly-owned subsidiary of United Therapeutics Corporation, announced today that it has been acquired by an investment group made up of current and past Medicomp management led by Dan Balda, MD, Medicomp's President and CEO....

TOPICS:
Advertisement

Noveko stock up sharply, reaching highest price since last summer

April 5, 2011 7:45 am | by The Associated Press | Comments

Noveko International Inc. (TSX:EKO) has seen its stock recover sharply recently, rising nearly 30 per cent Tuesday to hit the highest levels since last summer.The Montreal-based company stock traded as high as $1 early Tuesday, the highest since July 2010, before falling back later.Noveko's...

Phillip Morris buys stake in vaccine company

April 5, 2011 7:45 am | by The Associated Press | Comments

Philip Morris International Inc. bought more than $9 million worth of shares in Medicago Inc., roughly half of the equity offering from the Canadian biotech company.Philip Morris said Tuesday that the offering gives it 9.86 percent of Medicago's issued and outstanding shares. Medicago uses...

Penn Study Sheds Light on End of Life Management of Implanted Defibrillators

April 5, 2011 7:35 am | by University Of Pennsylvania | Comments

Each year, more than 100,000 patients in the U.S. undergo implantation of a new implantable cardioverter defibrillator (ICD) for heart rhythm abnormalities. This number constitutes a 20-fold increase over the last 15 years. Current medical guidelines advocate discussion of end of life...

TOPICS:

NuAire to Offer Adaptable Laboratory Centrifuges From Awel International

April 5, 2011 6:37 am | by Bio-Medicine.Org | Comments

PLYMOUTH, Minn., April 5, 2011 /- NuAire, a worldwide laboratory equipment supplier, has partnered with Awel International to bring a complete line of laboratory centrifuges to North and South American markets. Awel International, previously BMS International, has distributed NuAire...

TOPICS:

CareFusion Announces Departure of Chief Operating Officer

April 5, 2011 6:35 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 5, 2011 /- CareFusion (NYSE: CFN ), a leading global medical technology company, today announced Chief Operating Officer Dwight Winstead will leave the company on June 30. Winstead has served as COO since CareFusion separated from Cardinal Health on Sept. 1, 2009, during...

TOPICS:

Reportlinker Adds Leading Anti-Cancer Drugs: World Market Prospects 2011-2021

April 5, 2011 5:37 am | by Bio-Medicine.Org | Comments

NEW YORK, April 5, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Leading Anti-Cancer Drugs: World Market Prospects 2011-2021 http://www.reportlinker.com/p0470103/Leading-Anti-Cancer-Drugs-World-Market-Prospects-2011-2021.html What will...

TOPICS:

Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference

April 5, 2011 5:36 am | by Bio-Medicine.Org | Comments

ALISO VIEJO, Calif., April 5, 2011 /- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced that company management will present an overview of the company at the Future Leaders in the Biotech Industry Conference in New York City. Location: Millennium Broadway Hotel &...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading